Survival analysis of lung cancer data in KM plotter using an online Kaplan–Meier Plotter software revealed that patients with lung cancer exhibiting a high USP17 expression as high as 38.86% have a significantly lower survival rate than that of patients with a lower USP17 expression (Fig. 1b). The gene discussed is USP17L9P; the disease is lung carcinoma.